PDSB icon

PDS Biotechnology
PDSB

Overview Fund Activity

56 hedge funds and large institutions have $16.5M invested in PDS Biotechnology in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
-20
Holders Change %
-26.32%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
21
Closed
24
Calls
$1.35M
Puts
$278K
Net Calls
+$1.07M
Net Calls Change
+$500K

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$5.81M
2
Citadel Advisors
2
Citadel Advisors
Florida
$439K
3
XT
3
XTX Topco
Cayman Islands
$257K
4
SPA
4
Sherbrooke Park Advisers
New York
$153K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.59M

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$0
2
Northern Trust
2
Northern Trust
Illinois
$354K
3
Millennium Management
3
Millennium Management
New York
$895K
4
SI
4
Sofinnova Investments
California
$0
5
Jane Street
5
Jane Street
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
RIL
76
Rothschild Investment LLC
Illinois
– -$132 -45 Closed
Northwestern Mutual Wealth Management
77
Northwestern Mutual Wealth Management
Wisconsin
– -$82 -28 Closed
MG
78
Mather Group
Illinois
– -$40 -10 Closed
1 2 3
4